Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001901773 | SCV002173380 | pathogenic | Fanconi anemia | 2022-01-13 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with FANCI-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is present in population databases (rs748961800, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Ile279Serfs*7) in the FANCI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCI are known to be pathogenic (PMID: 17452773, 17460694). |
Baylor Genetics | RCV003464219 | SCV004197215 | likely pathogenic | Fanconi anemia complementation group I | 2023-11-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003464219 | SCV005631318 | likely pathogenic | Fanconi anemia complementation group I | 2024-05-16 | criteria provided, single submitter | clinical testing |